Blood Collection Market size is estimated at USD 11.7 billion in 2024 and is anticipated to reach USD 28.8 billion by the end of 2037, expanding at around 7.2% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of blood collection is assessed at USD 12.5 Billion.
The primary growth driver of the blood collection market is the increasing demand for blood and related products including cryoprecipitated AHF (cryo), red cells, platelets, plasma, and granulocytes to cater to diagnostics, surgical procedures, treatment of chronic diseases, and other healthcare needs. For instance, according to the American Hospital Association, by 2030, around 170 million people in the U.S. are predicted to have at least one chronic ailment, including hypertension, diabetes, heart disease, and arthritis.
The COVID-19 pandemic significantly influenced the blood collection market by highlighting the critical need for blood and plasma for treatment and research. Furthermore, the rise in cancer cases worldwide is driving the need for advanced blood collection products. For instance, the World Health Organization (WHO) estimates that more than 35 million new cancer cases are expected to be detected by 2050; this hike is pushing the need for advanced services including diagnostics.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.2% |
|
Base Year Market Size (2024) |
USD 11.7 billion |
|
Forecast Year Market Size (2037) |
USD 28.8 billion |
|
Regional Scope |
|
Product Type (Venous, Capillary)
In blood collection market, venous segment is predicted to dominate revenue share of over 80.5% by 2037. The rising number of surgical procedures and the growing need for medical equipment for diagnosis and detection is fuelling the growth of the segment. Venous blood samples are the gold standard for a wide range of diagnostic tests, leading to sustained demand. Moreover, manufacturers are investing heavily in the development of devices with enhanced safety such as safety needles and blood collection sets to mitigate contamination risks. Venous blood collection products are more reliable and consistent, which is driving their demand for accurate diagnostic results and long-term studies.
Method (Manual Blood Collection, Automated Blood Collection)
By 2037, manual blood collection segment is projected to account for blood collection market share of around 70.5%, owing to its cost-effectiveness and extensive use by hospitals, individual clinical laboratories, and pathology laboratories. Manual blood collection systems are less expensive compared to automated ones, which makes them accessible to a wide range of healthcare facilities.
Additionally, manual methods can be used in low-resource environments. For instance, according to the WHO, in 2021, 4.5 billion people worldwide lacked complete access to basic healthcare services, highlighting the need for simpler blood collection methods.
Application (Diagnostics, Treatment, Research)
Diagnostics segment is anticipated to capture blood collection market share of over 68.5% by 2037. The rising importance of preventive healthcare on regular blood testing for early detection of diseases is augmenting the demand for diagnostic blood collection products. This trend is expected to maintain its dominance as the healthcare sector expands, driving the reliance on blood-based diagnostics.
Moreover, companies specializing in diagnostic technologies often partner with hospitals and research institutions to develop and validate innovative tests for early cancer detection. These collaborations facilitate access to clinical data and patient samples, significantly boosting the demand for diagnostic testing. For instance, in 2023, Providence, a non-profit health system serving the Western U.S., and GRAIL, LLC, a healthcare company, announced the expansion of their partnership to include multi-cancer early detection screening as part of clinical care for eligible individuals across Providence health system. Through the collaboration, eligible patients at Providence's 52 hospitals and 900 clinics in seven states will have access to GRAIL's Galleri multi-cancer early detection (MCED) test as part of a broad range of health services.
Our in-depth analysis of the blood collection market includes the following segments:
|
Product Type
|
|
|
Method |
|
|
Application |
|
|
End user |
|
North America Market Forecast
North America blood collection market is anticipated to account for revenue share of around 45.5% by 2037. The presence of advanced healthcare infrastructure, the existence of key market players, and the increasing prevalence of diabetes are some of the factors boosting the blood collection market. Several blood donation initiatives by public and private organizations are also contributing to the blood collection system sales growth.
The U.S. is advancing in the field of healthcare with ongoing R&D activities leading to the development of next-gen medical devices including blood collection products. The rising prevalence of chronic disorders such as cancer and diabetes is also contributing to the blood collection market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), around 136 million adults in the U.S. are living with diabetes.
In Canada, the importance of blood, plasma, tissues, and organs is high, and several awareness programs conducted by public and private organizations such as Canadian Blood Services are increasing the sales of modern blood collection products in the country.
APAC Market Statistics
Asia Pacific blood collection market is expected to expand at a fast pace during the forecasted period owing to increasing healthcare expenditure. Governments in the region are investing heavily in advancing their healthcare infrastructure. Such aspects are generating high-earning opportunities for medical surgical and diagnostic solution producers in Asia Pacific particularly India, China, Japan, and South Korea.
India is witnessing a high growth in the healthcare sector, and the demand for medical professionals is expected to double by 2030. Also, the Government of India is promoting voluntary blood donation campaigns and establishing blood banks, which enhance the overall blood collection infrastructure. According to the Ministry of Health and Family Welfare, Government of India, there are 4153 licensed blood banks in the country as of 2023.
Companies Dominating the Blood Collection Landscape
Key players in the blood collection market are adopting various organic and inorganic strategies to boost their profit shares. They are investing heavily in R&D to introduce advanced blood collection products and attract a wider consumer base. Industry giants are also partnering with other players and collaborating with research organizations to enhance their distribution networks and product visibility. Leading companies are also focusing on regional expansion strategies to tap into new revenue streams.
Key players in the blood collection market are adopting various organic and inorganic strategies to boost their profit shares. They are investing heavily in R&D to introduce advanced blood collection products and attract a wider consumer base. Industry giants are also partnering with other players and collaborating with research organizations to enhance their distribution networks and product visibility. Leading companies are also focusing on regional expansion strategies to tap into new revenue streams.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?